In this regard, the Prevention of Mortality with Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites (PRECIOSA) trial (NCT03451292), which is currently recruiting, will hopefully improve the evidence base regarding long-term administration of albumin. This evidence concerns the gene ALB and Ascites.